Member Spotlight: Gilead Announces New Foster City Research Center

Earlier this month, Gilead announced the company’s intent to build a new Research Center on its Foster City campus. Gilead’s new Research Center will add new space for oncology and inflammation teams, which are expected to outgrow their current space. When completed, the facility will include new technology capabilities and create a highly collaborative hub for the company’s community of researchers. 
 
“At Gilead Sciences, we are inspired by the mission to improve the world for future generations. We live this out through our commitments to creating innovative research sites that enable our employees to pursue scientific breakthroughs,” said Joydeep Ganguly, Senior Vice President, Corporate Operations, Gilead Sciences. “We are proud to have one of the industry’s largest research-focused headquarters and are energized by the opportunity to deliver a new, world-class research center.”
 
The decision was driven by Gilead’s enterprise Master Plan, which includes a focus on creating an internal research infrastructure to catalyze the company’s ambitions in three therapeutic areas: inflammation, oncology and virology. This new research center will do just that by helping further accelerate and scale Gilead’s ability to create new solutions to serious medical challenges. The location for Gilead’s new Research Center is slated to include approximately 175,000 square feet of flexible, digitally enabled lab space. In addition, more than 45,000 square feet of existing office space will be reclassified as lab areas, enabling overall campus flow while creating increased lab concentration.